Financial Highlights

Financial Highlights
2020 FQ1 YTD
3/31/2020
2019 FY
12/31/2019
2018 FY
12/31/2018
2017 FY
12/31/2017
2016 FY
12/31/2016
Balance Sheet ($000)
Cash and Cash Equivalents 5,869 11,809 5,676 6,644 7,368
Investments 120,248 118,969 112,690 114,731 112,657
Total Assets 150,486 153,934 144,231 146,438 148,579
Total Policy Reserves 78,559 78,472 77,988 76,674 76,174
Total Liabilities 100,528 100,473 98,365 98,813 100,527
Total Mezzanine Level Items 0 0 0 0 0
Equity Attributable to Parent Company 49,958 53,461 45,866 47,625 48,052
Total Equity 49,958 53,461 45,866 47,625 48,052
Equity before Unrealized Gains 49,404 50,967 47,251 44,499 46,366
Total Equity/ Total Assets(%) 33.20 34.73 31.80 32.52 32.34
Reserves/ Equity(x) 1.57 1.47 1.70 1.61 1.59
Income Statement ($000)
Total Policy Income 14,955 59,883 60,856 61,163 61,398
Net Investment Income 365 4,593 3,651 3,649 4,059
Realized Gain on Securities (391) 2,338 (262) 232 831
Asset Management and Brokerage Fees 0 0 0 0 0
Total Revenue 15,074 67,399 64,857 65,640 66,893
Total Policy Expense 10,583 38,598 40,409 42,869 38,847
Underwriting & Other Expense 5,255 23,056 22,148 22,578 22,600
Total Expense 16,099 62,819 63,792 66,754 62,799
Net Income (860) 4,067 779 (1,203) 3,063
Net Income Attributable to Parent (860) 4,067 779 (1,203) 3,063
Operating Income after Taxes (78) 1,654 1,215 (1,355) 2,414
EBITDA (695) 6,110 2,612 707 5,749
Per Share Information ($)
Basic Book Value per Share 19.74 21.12 18.15 18.88 19.09
Book Value per Share before Unrealized Gains 19.52 20.14 18.70 17.64 18.42
Diluted EPS after Extraordinary (0.34) 1.61 0.31 (0.48) 1.22
EBITDA/ Share (0.27) 2.42 1.04 0.28 2.29
Operating EPS (0.03) 0.65 0.48 (0.54) 0.96
Price/ LTM Operating Earnings(x) 46.50 26.10 27.10 NM 18.50
Common Dividends Declared per Share 0.06 0.21 0.20 0.20 0.18
Dividend Payout Ratio(%) NM 13.04 64.52 NM 14.75
EPS after Extra Growth(%) NM 419.40 NM NM (34.80)
Profitability (%)
ROAA (2.26) 2.69 0.53 (0.81) 2.03
Operating ROAA (0.20) 1.09 0.83 (0.91) 1.60
ROAE (6.65) 8.02 1.67 (2.53) 6.36
ROATCE (6.65) 8.02 1.67 (2.53) 6.36
Operating ROAE (0.60) 3.26 2.60 (2.85) 5.01
Investment Yield (0.08) 5.50 2.82 3.21 3.99
Combined Ratio 107.60 100.10 101.31 102.25 94.59
P&C Stat Combined Ratio after Dividends NA NA NA NA NA
Reported Medical Care Ratio NA NA NA NA NA
Net Premiums Written/ Avg Equity(x) 1.19 1.19 1.30 1.29 1.28
Growth Rates and Trends (%)
Asset Growth (8.96) 6.73 (1.51) (1.44) 0.50
Equity Growth (26.21) 16.56 (3.69) (0.89) 7.06
Net Written Premium Growth (1.72) (0.50) (1.09) (0.22) 1.88
Recurring Revenue Growth (16) 3.92 (1.19) (1.87) 4.44
Net Income Growth NM 422.08 NM NM (34.79)
Assets Five-year CAGR 0.47 1.22 1.48 1.53 2.25
Equity Five-year CAGR 2.47 4.57 6.50 9.51 4.79
Revenue Five-year CAGR (1.19) 0.92 1.18 1.98 1.50
Net Income Five-year CAGR NM (11.79) (32.72) NM NM
Miscellaneous ($000)
Net Premiums Written 15,331 60,411 60,717 61,388 61,525
Gross Life Insurance in Force NA 202,663 203,209 206,826 208,420
Total Membership(actual) 0 0 0 0 0
Assets Under Management 0 0 0 0 0
Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.
Copyright 2020, © S&P Global Market Intelligence  Terms of Use